FTC Wins Access To AndroGel Docs In AbbVie Antitrust Suit
By Alex Wolf ( August 25, 2016, 5:30 PM EDT) -- Pharmaceutical company AbbVie must hand over to the U.S. Federal Trade Commission a trove of various documents and presentation materials that it claimed were privileged in the FTC's pay-for-delay suit over testosterone replacement treatment AndroGel because it failed to show attorney-client protections, a Pennsylvania federal judge ruled Thursday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.